RxDoctor Payments Data

Mark Spangehl, MD

Orthopaedic Surgery · Phoenix, AZNPI 1568447191

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $38,984 of the $45,582 with a category attached, or 85.5%. 10 manufacturers reported payments, led by Bodycad USA Corp at 54.0% of the total. Reporting peaked in 2019 at $28,203 and has fallen 71.5% since, to $8,051 in 2025.

$45,582in general payments, 2019–2025

Across 61 payments — averaging $747.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bodycad USA Corp$25K
  • Zimmer Biomet$10K
  • Davol Inc.$7K
  • Stryker$3K
  • Heraeus Medical, LLC.$625
  • Smith+Nephew$268
  • plus $356 from 4 others
$84,202in research payments, 2019–2025

Across 39 payments — averaging $2159.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$82K
  • Zimmer Biomet$2K

What the payments were for

  • Consulting fees$38,98486%
  • Travel & lodging$2,7936%
  • Food & beverage$3,8058%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,582 in reported general payments places this provider in the 85th percentile of 377 orthopaedic surgery providers in Arizona.

See all orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$207,703
Medicare patients
409
Services billed
614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin28$28
Clindamycin Hcl12$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →